A clinical trial for acute bronchitis in children

A clinical evaluation of Lavangadhi kuligai a Siddha drug for Kabasuram(Acute bronchitis) in children

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/02/006633

Enrollment

Registered

2016-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Fever Dry or productive cough, running nose, Constipation.

Interventions

Intervention1: Lavangadhi kuligai: 56 mg tablet orally for one day Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Fever Dry or productive cough running nose Constipation

Exclusion criteria

Exclusion criteria: Temperature > 102Ë?F Fever > 4 Days Convulsions Typhoid Malaria Active primary complex Pneumonia

Design outcomes

Primary

Measure	Time frame
Releif of symptomsTimepoint: Releif of symptoms	—

Secondary

Measure	Time frame
Efficacy of the drugTimepoint: Nil	—

Countries

India

Contacts

Public ContactDrKVennila

National Institute of Siddha

kalyas53@gmail.com9444946270

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026